Expression of FADS2, an enzyme important for the viability and self-renewal of GBM cancer stem cells [20], is higher in GBM tumors than in healthy brain tissue, according to GEPIA [9] and the transcriptomics analysis performed by Seifert et al. [8]. Here, FADS2 is linked to glioblastoma.